JONES KENNETH T (See Remarks) sold 2.8% of their position (2.50K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/14/2023ACC: 0001062993-23-018019
Officer· See Remarks
Since Aug 2023
+6.50K
Net shares
Net buyer
$3.3K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
9K acquired · 2.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9K
Price / share
—
Trade value
—
% of position
11.4%
9/12/2023
79.03K→88.03K
Common Stock
Direct
Shares
−2.50K
Price / share
$1.33
Trade value
$3.32K
% of position
2.8%
9/13/2023
88.03K→85.52K
Total
Net shares
+6.50K
Net value
-$3.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/12/2023 | A · Award | +9K | — | — | 11.4% | 79.03K | 88.03K |
| Common Stock Direct | 9/13/2023 | S · Sale | −2.50K | $1.33 | $3.32K | 2.8% | 88.03K | 85.52K |
| Total | +6.50K | -$3.32K | ||||||
Derivative Transactions0
No derivative transactions reported